Biomarkers as Predictors of Suicidal Risk in Adolescents (NCT03014518) | Clinical Trial Compass
CompletedNot Applicable
Biomarkers as Predictors of Suicidal Risk in Adolescents
United States80 participantsStarted 2016-12
Plain-language summary
Suicide is one of the most devastating events in society at all levels. The primary goal of this study is to predict suicide in adolescents at risk. We will utilize blood biomarker measurement and clinical risk factor scales to develop a tool to identify adolescents at risk for suicide earlier, which will allow clinicians to prescribe timely treatment and prevent suicide.
Who can participate
Age range
12 Years – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Suicide Attempt Study Group:
* 12-18 years of age
* admitted to the Cleveland Clinic inpatient child and adolescent psychiatry unit after suicidal ideations or a suicide attempt
Healthy Control Group:
* 12-18 years of age
* No history of suicide attempt
Exclusion Criteria:
Suicide Attempt Study Group:
* History of autism spectrum disorder
* Non-verbal
* Moderate or severe intellectual disability (IQ\<70 and patients in special education full-time)
* Schizophrenia or schizoaffective disorder diagnosis
* Current diagnosis of anorexia or bulimia
* History of generalized tonic-clonic epileptic seizures in last 3 months (If patient does not have a history of seizures, and generalized tonic-clonic seizure was clinically determined to be caused by patient's recent overdose attempt, patient can still be recruited for study if 24 hours has passed since last seizure)
* History of traumatic brain injury, brain tumor, or any major neurological disorder
* Delirium or mood disorder secondary to general medical condition
* Current infection, fever, antibiotic use in the last 2 weeks
* History of autoimmune or immunodeficiency diseases
* Current untreated major endocrine disorder
* Current pregnancy or delivery within the last month
* Diagnosed malnutrition
* Positive urine toxicology for benzodiazepines or opiates on admission
* Current substance use disorder diagnosis and referral for CD assessment upon discharge
* Current diagnosis of morbid obesity or a current…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Relation between levels of peripheral inflammatory markers and suicide attempt
Timeframe: baseline
2
Relation between levels of peripheral inflammatory markers and suicide attempt
Timeframe: on the date of discharge from hospital inpatient unit (average length of admission = 5 days)